Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of ...
New York, NY December 11, 2025 --Today, Questex’s Chief Medical Officer Summit 360° (CMO 360°) announces the agenda and keynote speakers for the 14th annual conference uniquely designed for the ...
Jonas Hannestad, MD, PhD, is the CMO and Head of R&D at Tranquis Therapeutics. Can you first talk about your role as the CMO of Tranquis Therapeutics? My role here at Tranquis has three main parts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results